Siren Healthcare

Operator of a biotech company intended to provide a gene therapy platform for a variety of cancer treatments. The company's therapies combine the two transformative therapeutic technologies, AAV gene therapy, and cytokine immunotherapy, into a single transformative modality and utilize cytokine immunotherapies, enabling users to overcome delivery, efficacy, toxicity, and other associated challenges.

Lux Capital

Founders Fund

🏥 Healthcare